Related Experiment Video
Updated: May 7, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Prophylactic temporary mechanical circulatory support: The new paradigm in cardiac surgery
Silvia Mariani1,2, Gabor Bari2,3, Paolo Meani2,4
1Cardiac Surgery Unit, Cardio-Thoracic and Vascular Department, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
Prophylactic temporary mechanical circulatory support (tMCS) offers proactive cardio-circulatory protection in high-risk cardiac surgery patients, shifting from reactive rescue therapy. Early data are promising but require further trials to define its role.
Area of Science:
- Cardiology
- Cardiac Surgery
- Mechanical Circulatory Support
Background:
- Post-cardiotomy cardiogenic shock (PCCS) is a lethal complication of cardiac surgery with high mortality.
- Current rescue therapy with temporary mechanical circulatory support (tMCS) has suboptimal outcomes due to delayed initiation.
- This review explores prophylactic tMCS as a strategy within "protected cardiac surgery".
Purpose of the Study:
- To summarize current PCCS management concepts.
- To evaluate the emerging role of prophylactic tMCS in cardiac surgery.
- To provide a framework for timely intervention and metabolic stabilization.
Main Methods:
- A narrative review of international guidelines, expert consensus statements, and observational studies.
- Focus on PCCS pathophysiology, indications, timing, and device selection.
- Analysis of prophylactic tMCS strategies in high-risk scenarios.
Main Results:
- Prophylactic tMCS is used in high-risk cases like acute coronary syndromes, valvular dysfunction, and complex weaning from bypass.
- "Protected cardiac surgery" concepts (preoperative, intraoperative) offer a framework for preventing low cardiac output syndrome.
- Successful implementation requires multidisciplinary Heart Team decisions, hemodynamic assessment, and tailored strategies.
Conclusions:
- Prophylactic tMCS signifies a paradigm shift towards proactive cardio-circulatory protection in select high-risk patients.
- Early observational data are encouraging but require prospective trials.
- Standardized risk stratification and cost-effectiveness analyses are needed to define its role.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies

